New Model Estimates Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis BJanuary 17, 2025GastroenterologyGastrointestinal Cancer
Red Wine May Not Be a Health Tonic, But Is It a Cancer Risk?January 13, 2025Preventive CarePatient & Survivor CareGastroenterologyGastrointestinal CancerBreast CancerHead & Neck/Thyroid Cancers
Dietary Calcium Cuts Colorectal Cancer Risk by 17%January 9, 2025Gastrointestinal CancerPatient & Survivor CarePreventive CareGastroenterology
MRI-Invisible Prostate Lesions: Are They Dangerous?January 9, 2025Genitourinary CancerPreventive CareSarcoma & GISTPatient & Survivor CareNonmelanoma Skin CancerNeuro-oncologyMixed Topics
KRAS Mutations Linked to Varied Treatment Outcomes in Metastatic Pancreatic CancerJanuary 9, 2025Gastrointestinal CancerGastroenterologyPatient & Survivor Care
Does Watch and Wait Increase Distant Metastasis Risk in Rectal Cancer?January 8, 2025Gastrointestinal CancerGastroenterologyPreventive Care
Cellular Therapies for Solid Tumors: The Next Big Thing?January 6, 2025MelanomaPractice ManagementPatient & Survivor CareNeuro-oncologyGastroenterologyCNS/Brain CancerGastrointestinal Cancer
AI-Aided Colonoscopy’s ‘Intelligent’ Module Ups Polyp DetectionJanuary 6, 2025GastroenterologyGastrointestinal Cancer
Hepatocellular Carcinoma: Leading Causes of Mortality PredictedDecember 24, 2024Gastrointestinal CancerGastroenterologyMixed Topics
Does Intensive Follow-Up Testing Improve Survival in CRC?December 16, 2024Gastrointestinal CancerGastroenterology
Some Antihypertensives Linked to HCC Risk in Patients With MASLD and CirrhosisDecember 16, 2024GastroenterologyGastrointestinal Cancer
New Cancer Drugs: Do Patients Prefer Faster Access or Clinical Benefit?December 12, 2024Patient & Survivor CarePractice ManagementMixed TopicsBreast CancerCNS/Brain CancerDLBCLFollicular Lymphoma
Could Diet and Gut Bacteria Be Fueling Early CRC?December 10, 2024Gastrointestinal CancerGastroenterology
New Cancer Vaccines on the Horizon: Renewed Hope or Hype?December 6, 2024Preventive CarePatient & Survivor CareImmunotherapyImmuno-oncologyMixed TopicsGynecologic CancerGenitourinary Cancer
FDA Approves Bizengri for NSCLC and Pancreatic Cancers Harboring NRG1 Gene FusionDecember 5, 2024Lung CancerPatient & Survivor CareGastrointestinal CancerMixed TopicsGastroenterology
